Success Metrics

Clinical Success Rate
100.0%

Based on 1 completed trials

Completion Rate
100%(1/1)
Active Trials
2(67%)
Results Posted
0%(0 trials)

Phase Distribution

Ph not_applicable
2
67%
Ph phase_1
1
33%

Phase Distribution

1

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution3 total trials
Phase 1Safety & dosage
1(33.3%)
N/ANon-phased studies
2(66.7%)

Highest Phase Reached

Phase 1

Trial Status & Enrollment

Completion Rate

100.0%

1 of 1 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

2

trials recruiting

Total Trials

3

all time

Status Distribution
Active(2)
Completed(1)

Detailed Status

Recruiting2
Completed1

Development Timeline

Analytics

Development Status

Total Trials
3
Active
2
Success Rate
100.0%
Most Advanced
Phase 1

Trials by Phase

Phase 11 (33.3%)
N/A2 (66.7%)

Trials by Status

recruiting267%
completed133%

Recent Activity

2 active trials
Showing 3 of 3
recruitingphase_1

Nicotinic Receptor Genetic Variation and Alcohol Reward

NCT03294460
recruitingnot_applicable

Social Facilitation of Alcohol Effects and Alcohol Misuse in Young Adults

NCT06627803
completednot_applicable

Cannabis Impairment Detection Application (CIDA)

NCT04230460

Clinical Trials (3)

Showing 3 of 3 trials
NCT03294460Phase 1

Nicotinic Receptor Genetic Variation and Alcohol Reward

Recruiting
NCT06627803Not Applicable

Social Facilitation of Alcohol Effects and Alcohol Misuse in Young Adults

Recruiting
NCT04230460Not Applicable

Cannabis Impairment Detection Application (CIDA)

Completed

All 3 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
3